Derick Lau
Impact in
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
- Oncology top 2%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 34
- Lung Cancer Diagnosis and Treatment 23
- Oncology 38
- Lung Cancer Research Studies 19
- Cancer Treatment and Pharmacology 8
- Peptidase Inhibition and Analysis 6
- Co-authors
- David R. Gandara (61 shared papers)Primo N. Lara (38 shared papers)Allen M. Chen (11 shared papers)John J. Crowley (8 shared papers)D. Gregory Farwell (10 shared papers)James A. Purdy (9 shared papers)Kari Chansky (7 shared papers)Kit S. Lam (9 shared papers)
- Journals
- Journal of Thoracic Oncology (12 papers)Clinical Lung Cancer (10 papers)Journal of Clinical Oncology (9 papers)International Journal of Radiation Oncology*Biology*Physics (8 papers)Lung Cancer (7 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Derick Lau
110 papers receiving 3.7k citations
Derick Lau's Hit Papers
Peers
Comparison fields: 5 of 115
- Otorhinolaryngology 439
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 1.3k
- Cancer Research 297
- Speech and Hearing 98
Countries citing papers authored by Derick Lau
This map shows the geographic impact of Derick Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derick Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derick Lau more than expected).
Fields of papers citing papers by Derick Lau
This network shows the impact of papers produced by Derick Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derick Lau. The network helps show where Derick Lau may publish in the future.
Co-authors
The 25 scholars most cited alongside Derick Lau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 485 | |
| 2 | Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023 Hit paper breakdown → | 2008 | 422 |
| 3 | 2010 | 161 | |
| 4 | 1999 | 147 | |
| 5 | 2010 | 123 | |
| 6 | 2006 | 114 | |
| 7 | 2005 | 103 | |
| 8 | 2004 | 83 | |
| 9 | Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. | 1991 | 82 |
| 10 | 2009 | 82 | |
| 11 | 2001 | 80 | |
| 12 | 2005 | 70 | |
| 13 | 2014 | 68 | |
| 14 | 2012 | 51 | |
| 15 | 2010 | 51 | |
| 16 | 2002 | 51 | |
| 17 | 2006 | 49 | |
| 18 | 2004 | 46 | |
| 19 | 2012 | 45 | |
| 20 | 2012 | 45 |
About Derick Lau
Derick Lau is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Otorhinolaryngology and Radiology, Nuclear Medicine and Imaging, having authored 111 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Diagnosis and Treatment (23 papers), Lung Cancer Research Studies (19 papers), Cancer Treatment and Pharmacology (8 papers), Peptidase Inhibition and Analysis (6 papers), Head and Neck Cancer Studies (6 papers), Cancer therapeutics and mechanisms (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Otorhinolaryngology (439 citations), Oncology (1.1k citations), Pulmonary and Respiratory Medicine (1.3k citations), Cancer Research (297 citations) and Speech and Hearing (98 citations). Derick Lau has collaborated with scholars based in United States, Canada and China. Frequent co-authors include David R. Gandara, Primo N. Lara, Allen M. Chen, John J. Crowley, D. Gregory Farwell, James A. Purdy, Kari Chansky, Kit S. Lam, Quang Luu and James R. Jett. Their work appears in journals such as Journal of Thoracic Oncology, Clinical Lung Cancer, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.